Invicro
linkedin
twitter
facebook
google_plus
youtube
email
Subscribe to Industry Content
  • Solutions
    • Clinical Imaging
      • Imaging in Clinical Neuroscience and Neurology
      • Clinical Imaging Core Lab
    • Nonclinical Imaging
    • Analytics
    • Data Management
    • Ex-Vivo and Pathology Services
    • Radio and Medicinal Chemistry
  • Software
    • VivoQuant® – Visualization and Analysis
    • iPACS® – Data Management
  • Insight Areas
    • Translational Design
    • Therapeutic Area Experience
    • Imaging Informatics
  • Our Approach
  • Publications
    • Publications Archives
    • Case Studies
    • Resources
  • About Us
    • Careers
    • News
    • Events & Webinars
    • The Team
    • Sites and Partners
  • Contact Us

Home » Archived News

<< Back to Recent News


  • Events: Invicro at WMIC 2016

    BOSTON, MA (August 26, 2016) – Read more about our attendance at WMIC, including presentations by our team.  SEE MORE

  • Webinar: High-Throughput Three-Dimensional Tissue Imaging in the Bright-Field, Fluorescence and Nuclear Regimes | June 8 | 11am EST

    In this talk, Jack Hoppin, Invicro co-founder, focuses on the strengths and limitations of these emerging translational tomographic techniques and technologies and evaluates their application as imaging biomarker tools.

    Get access to the recorded webinar here.

  • Events: Invicro at SNMMI 2016

    BOSTON, MA (June 10, 2016) – Read more about our attendance at SNMMI, including presentations by our team.  SEE MORE

  • News: Invicro Featured in WMIS Video Contest

    BOSTON, MA (June 8, 2016) – Invicro is the proud winner of the 2015 WMIS “This is Our Lab” Contest.  Winners were featured in a video to showcase their work, and the final product has been released on the WMIS website.  SEE MORE

  • Event: Invicro Hosts Translational Imaging Symposium in Boston

    BOSTON, MA (May 12, 2016) Leaders in translational molecular imaging will be presenting on the latest innovations and emerging global trends in the field. We look forward to hosting another event which will provide a forum for thought-leaders in translational imaging to share insights into the latest advancements in the field. SEE MORE

  • News: AXT Brings Invicro’s Preclinical Medical Imaging Products to Australia

    BOSTON, MA (April 5, 2016) AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of Invicro’s innovative software platforms. SEE MORE

  • News: Invicro Acquires Molecular NeuroImaging (MNI) to Establish Full Spectrum Translational Imaging Capabilities

    BOSTON, MA (February 25, 2016) – Invicro, LLC, and Molecular NeuroImaging, LLC, both leading providers of imaging service solutions and analysis software for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the spectrum of drug development. Invicro has acquired MNI and MNI will operate as a division of Invicro. SEE MORE

  • News: Invicro UK launches MIAKAT™ – software package for the quantitative analysis of PET neuroimaging data — Invicro

    SEE MORE
  • News: Invicro UK drives innovation in imaging – announcing winners of its IMPETus 2015 Pilot Grants — Invicro

    SEE MORE
  • News: PET imaging enhanced immuno-oncology drug development — Invicro

    SEE MORE
  • News: Magnetic resonance imaging reveals the complementary effects of decongestant and Breathe Right Nasal Strips on internal nasal anatomy — Invicro

    SEE MORE
  • News: Possible cognitive impairments found in some HIV-positive patients despite effective treatment — Invicro

    News: Possible cognitive impairments found in some HIV-positive patients despite effective treatment — InvicroSEE MORE
  • News: Update on MIAKAT™ — Invicro

    SEE MORE
  • News: Introduction to i-Biomarkers and preclinical sciences — Invicro

    SEE MORE
  • , now physically on the ground — Invicro”]SEE MORE
  • News: Yale team makes breakthrough that will transform the way we study CNS diseases — Invicro

    SEE MORE
  • News: Events: Invicro UK delivers 11 presentations at NRM2016 — Invicro

    SEE MORE
  • News: Invicro UK, in collaboration with Roche and Imperial, characterise radio-tracer for imaging addiction pathways — Invicro

    SEE MORE
  • News: Invicro UK is proud to be involved with the DPUK — Invicro

    SEE MORE
  • News: Invicro UK plays central role in world’s most in-depth study to detect Alzheimer’s and identify early signs of the disease — Invicro

    SEE MORE
  • News: PET/MRI scanner installed at Invicro UK — Invicro

    SEE MORE
  • News: Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis – A PET/MRI Study — Invicro

    SEE MORE
  • News: Gut Hormones in Addiction (GHADD) Study at Hammersmith Hospital — Invicro

    SEE MORE
  • News: New Imaging biomarkers (ligands) available at Invicro UK

    SEE MORE
  • News: Invicro UK among the Scrip Awards' finalists — Invicro

    SEE MORE
  • News: Invicro UK strives to image Neurodegenerative Disease pathways to improve drug development — Invicro

    SEE MORE
  • News: Imaging+ – advanced translational imaging for CNS Drug Development — Invicro

    SEE MORE
  • News: Does Alzheimer's Disease pathology spread across the brain? Invicro UK answers this for b-amyloid — Invicro

    SEE MORE
  • News: Gaming Technology Helps Dementia Imaging — Invicro

    SEE MORE
  • Events: Invicro UK at BRAIN 2015 — Invicro

    SEE MORE
  • News: PET Rocks! — Invicro

    SEE MORE
  • News: Invicro UK in September's Nature Biopharma Dealmakers — Invicro

    SEE MORE
  • News: Applications for the 4th IMPETus Pilot Grants Programme now open! — Invicro

    SEE MORE
  • News: Improved experience for Dementia sufferers during imaging – Invicro UK’s clinical team complete Alzheimer’s Society expert training program — Invicro

    SEE MORE
  • News: It all starts with a thought! — Invicro

    SEE MORE
  • News: Learn new things everyday! — Invicro

    SEE MORE
  • News: A week dedicated to Nuclear Medicine & Molecular Imaging — Invicro

    SEE MORE
  • News: Yale invasion continues at Invicro UK — Invicro

    SEE MORE
  • Events: Invicro UK at EANM'15 in Hamburg — Invicro

    SEE MORE
  • News: Breakthrough in development of treatment for schizophrenia — Invicro

    SEE MORE
  • News: Nature Publication's BioPharma Dealmakers has a feature on Invicro UK

    SEE MORE
  • News: Featured Article in PMB — Invicro

    SEE MORE
  • News: Invicro UK and Imperial College collaborate on state-of-the-art imaging for dementia drug research — Invicro

    SEE MORE
  • News: Invicro UK collaborates with Teva and UCL on unique Brain Imaging Study aimed at unlocking A New Approach in Neurodegenerative Disease — Invicro

    SEE MORE
  • News: What if we could really read the brain? — Invicro

    SEE MORE
  • News: Invicro UK opens call for IMPETUS PET pilot awards — Invicro

    SEE MORE
  • News: Kevin Cox to Chair Session at Genesis 2014 Conference — Invicro

    SEE MORE
  • News: Invicro UK creates its first imaging biomarker for CNS research — Invicro

    SEE MORE
  • Events: Invicro Hosts Software User Meeting

    BOSTON, MA (September 29, 2015) – Invicro’s first Software User Meeting was held on September 23rd at Boston’s District Hall, and was attended by more than 70 Invicro software users (in person and remote). SEE MORE

  • Publications: Invicro Scientific Presentations at WMIC 2015

    Abstracts:

    Cryoflourescence Tomography (CFT) is an Ex Vivo Tool to Study Anatomy, Physiology, and Drug or Tracer Distribution in Brain and Other Organs SEE MORE

  • Events: Invicro at the 2015 World Molecular Imaging Congress

    BOSTON, MA (September 29, 2015) – Five Invicro teammates were pleased to attend September’s World Molecular Imaging Congress and continued to focus on fostering industry and academia relations… SEE MORE

  • News: Invicro Expands Preclinical Histology Service Capabilities with the Opening of Invicro Seattle

    Invicro expands 2D/3D histology imaging and analysis services for research and drug development  

    BOSTON, MA (March 20, 2015) – Invicro announced today its expansion of histology capabilities with the acquisition of a Seattle-based histology team and the opening of Invicro Seattle. SEE MORE

    • Software Release: Introducing VivoQuant® 2.0

      BOSTON, MA (February 25, 2015) – Invicro is excited to announce the release of VivoQuant® 2.0! Based on the valuable feedback of our customers, we have improved VivoQuant®’s user experience, making it more intuitive and even easier to interact with.  FUJIFILM VisualSonics Inc., a world leader in real-time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and a subsidiary of FUJIFILM SonoSite, Inc, is pleased to announce a new and exclusive partnership with Invicro, LLC, and the development of the VisualSonics iPACS® Imaging Study Management System. SEE MORE

    • News: Invicro Expands Translational Imaging Capacity with Cyclotron Facility

      BOSTON, MA (May 26, 2015) – Born out of a strategic partnership between Invicro, MPI Research, and 3D Imaging, the TIC features the only industry-owned and -operated cyclotron facility with contiguous vivarium facilities in the world.  SEE MORE

    • Events: Governor Patrick Visits Invicro, Celebrates New Collaboration Stemming From Israel Trade Mission

      BOSTON, MA (December 1, 2014) – Last week Governor Deval Patrick visited Invicro, a fast-growing Boston life sciences firm, to join in announcing the company’s expanded development agreement with Israel-based Aspect Imaging.  SEE MORE

    • Events: Invicro to Host Translational Imaging Symposium Featuring Leading Imaging Scientists in Drug Development and Research

      BOSTON, MA (October 7, 2014) – Invicro, a leading provider of imaging service solutions and analysis software for drug discovery and development, will host its second Translational Imaging Symposium on Thursday October 9th at District Hall in Boston’s Innovation District. SEE MORE

    • News: Invicro’s Three Year Growth Rate of 687% Earns Second-Consecutive Appearance on Inc. Magazine’s 500 | 5000 list

      BOSTON, MA (September 2, 2014) – Invicro recognized as one of the top 700 fastest growing private companies in the United States and No. 20 in Boston metro area  SEE MORE

    • News: Jack Hoppin, Ph.D., Co-Founder and Managing Director of Invicro, LLC, joins the Board of Trustees of the WMIS

      BOSTON, MA (August 26, 2014) – Invicro is pleased to announce the selection of co-founder and Managing Director Jack Hoppin, Ph.D., to the Board of Trustees of the World Molecular Imaging Society (WMIS). SEE MORE

    • News: Translational Imaging Center to Speed Drug Development, Lower Costs

      Mattawan, MI (February 4, 2014) – MPI Research, Invicro, and 3D Imaging today formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Michigan.  SEE MORE

    • News: INVICRO named the 327th fastest growing company and 20th in the top 100 Health Companies

      Boston, MA (August 22, 2013) – Invicro, LLC, a leading imaging services and software organization, has been named the 327th fastest growing company in the USA according to the Inc. Magazine 5000 list released this week. SEE MORE

    • News: INVICRO, MPI Research, and 3D Imaging Announce Strategic Partnership

      BOSTON, MA (June 14, 2013)– Invicro, an industry-leading imaging software and contract research organization, is pleased to announce a strategic partnership with MPI Research and 3D Imaging to unite world-class molecular imaging, radiochemistry, and informatics to accelerate drug discovery and development. SEE MORE

    Contact the Author:

    Amanda Harrell | T. +1 215-644-3409 | E. aharrell@invicro.com

    Share this page:
    • Linkedin
    • Twitter
    • Facebook

    February Webinar

    How MRI is Helping to De-risk Drug Development

                                                                            In this webinar, we will be reviewing MRI’s role in drug development with specific examples in areas such as neurology, oncology, as well as its future development with the incorporation of advance analytics such as deep learning.

    -Register Here-


        Recent News Archived News Events Subscribe to Industry Content Contact Us Publications

        Contact Us:

        t: +1 617-904-2100 | info@invicro.com | 27 Drydock Avenue | Boston, MA 02210

        Our Policies

        FCOI Policy
        Privacy Statement

        Copyright (c) Invicro, LLC 2018
        linkedin
        twitter
        facebook
        google_plus
        youtube
        email
        We use cookies on our website to offer you the best visitor browsing experience.
        You can find out more about how we use cookies and how to opt-out by clicking here. Accept Reject